Biocept Announces One-for-Ten Reverse Stock Split
SAN DIEGO, Sept. 4, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide...
Day: September 4, 2020
Humanigen Announces One-for-Five Reverse Stock Split; Reverse Split Facilitates Potential Uplisting to Nasdaq
BURLINGAME, CA / ACCESSWIRE / September 4, 2020 / Humanigen, Inc. (OTCQB:HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing...
Dawn of hope: Global cooperation in COVID-19 vaccine development
BEIJING, Sept. 4, 2020 /PRNewswire/ -- A news report by China.org.cn on international cooperation for vaccine R&D and China's recent...
Columbia Care to Participate in Upcoming Investor Conferences
NEW YORK, NY / ACCESSWIRE / September 4, 2020 / Columbia Care Inc. (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (FSE:3LP) ("Columbia Care" or...
New American Kidney Fund Education Initiative Provides Expanded Resources for Patients with and at Risk for Polycystic Kidney Disease
ROCKVILLE, MD / ACCESSWIRE / September 4, 2020 / The American Kidney Fund (AKF) today announced a new education initiative focused on...
Leading Veterinary Professional Dr. Anthony S. Johnson Featured in New Exclusive Interview with Kivo Daily
Dr. Anthony S. Johnson, DVM, DACVECC, a leading veterinary professional and current Medical Director of the Veterinary Information Network (VIN),...
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development and Production Capacity Expansion
Ministry submits official notification of funding to CureVac Grant as part of special program to accelerate COVID-19 vaccine development TÜBINGEN,...
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference
SHELTON, CT / ACCESSWIRE / September 4, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in...
Glaukos Announces Participation in September Investor Conferences
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Dr. Adel Quttainah: Successfully Combines Cosmetic Medicine and Surgery
NEW YORK, NY / ACCESSWIRE / September 4, 2020 / Dr. Adel Quttainah is no stranger to making history. After...
World High Life Investment Strategy Update
Love Hemp momentum provides World High Life team with the opportunity to focus investment attention on innovative applications for medicinal...
Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
GENEVA, SWITZERLAND / ACCESSWIRE / September 4, 2020 / RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief" or the...